share_log

PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%), etc.

PharmaCyte Biotech | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%)等

SEC announcement ·  2023/05/19 17:19
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息